Keeler Thomas Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-10,905
Closed -$529K 84
2020
Q4
$529K Sell
10,905
-11,449
-51% -$565K 0.3% 59
2020
Q3
$1.12M Sell
22,354
-6,771
-23% -$349K 0.71% 44
2020
Q2
$1.49M Buy
29,125
+16,825
+137% +$818K 1.07% 36
2020
Q1
$537K Sell
12,300
-17,350
-59% -$830K 0.63% 42
2019
Q4
$1.49M Sell
29,650
-150
-0.5% -$7.03K 1.06% 34
2019
Q3
$1.38M Buy
29,800
+4,400
+17% +$190K 1.06% 32
2019
Q2
$1.1M Buy
25,400
+2,000
+9% +$85K 0.88% 38
2019
Q1
$1.04M Buy
23,400
+8,300
+55% +$356K 0.87% 37
2018
Q4
$655K Buy
15,100
+1,100
+8% +$48.5K 0.76% 37
2018
Q3
$625K Hold
14,000
0.52% 45
2018
Q2
$560K Buy
14,000
+2,700
+24% +$106K 0.52% 44
2018
Q1
$452K Sell
11,300
-3,400
-23% -$141K 0.45% 44
2017
Q4
$632K Buy
+14,700
New +$678K 0.58% 37

Other funds holding SNY

Keeler Thomas Management's SNY Position: Q1 2021 in Review

Keeler Thomas Management sold out of Sanofi (SNY) in Q1 2021, closing a stake of 10,905 shares — an estimated $529K sold.

Keeler Thomas Management first reported a position in SNY in Q4 2017 and held it in 13 quarters. The position peaked at $1.49M in Q4 2019. 573 funds tracked by Wall St. Rank hold SNY as of Q1 2021.

  • Keeler Thomas Management reported no remaining Sanofi position as of Q1 2021 after selling out during the quarter.
  • Keeler Thomas Management sold 10,905 Sanofi shares in Q1 2021, an estimated $529K.
  • Keeler Thomas Management first reported a position in Sanofi in Q4 2017 and held it in 13 quarters.
  • Keeler Thomas Management's Sanofi position peaked at $1.49M in Q4 2019.
  • 573 funds tracked by Wall St. Rank held Sanofi as of Q1 2021.

Based on Keeler Thomas Management's 13F filing for Q1 2021, filed 23 Apr 2021.